Cadrenal Therapeutics, Inc. (CVKD) › Operating IncomeCadrenal Therapeutics, Inc. (CVKD) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2023: -$7.63M2024: -$10.96M2025: -$13.46M-$13.46M2023Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$13.46M-22.8%2024-$10.96M-43.6%2023-$7.63M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share